Luyan Pharma Co.,Ltd. (SHE:002788)

China flag China · Delayed Price · Currency is CNY
11.85
+0.14 (1.20%)
May 29, 2026, 3:04 PM CST
Market Cap4.60B +46.8%
Revenue (ttm)21.42B +4.5%
Net Income277.50M -16.7%
EPS0.71 -16.4%
Shares Out 388.52M
PE Ratio16.70
Forward PEn/a
Dividend0.35 (2.95%)
Ex-Dividend DateJul 10, 2025
Volume18,323,450
Open12.36
Previous Close11.71
Day's Range11.60 - 12.36
52-Week Range7.90 - 28.29
Beta0.11
Analystsn/a
Price Targetn/a
Earnings DateAug 18, 2026

About Luyan Pharma

Luyan Pharma Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products in China. The company distributes medicines, Chinese herbal medicines, medical devices, and others; and provides medical care, elderly care, and wellness services. It also operates pharmaceutical retail chains. The company was formerly known as Luyan (Fujian) Pharma Co. Ltd. and changed its name to Luyan Pharma Co.,Ltd. in June 2016. Luyan Pharma Co.,Ltd. was founded in 1992 and is headquartered in Xiamen,... [Read more]

Sector Healthcare
Founded 1992
Employees 5,722
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002788
Full Company Profile

Financial Performance

In 2025, Luyan Pharma's revenue was 21.25 billion, an increase of 3.79% compared to the previous year's 20.47 billion. Earnings were 280.88 million, a decrease of -18.74%.

Financial Statements